The ins and outs of a polyglutamine neurodegenerative disease: Spinocerebellar ataxia type 1 (SCA1)

Neurobiology of Disease

Volumn 7, Issue 3, 2000, Pages 129-134

  Orr, Harry T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE;

CEREBELLAR ATAXIA; DEGENERATIVE DISEASE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PURKINJE CELL; REVIEW; SPINOCEREBELLAR DEGENERATION; TRANSGENIC MOUSE;

EID: 0034210773     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0305     Document Type: Review

References (31)

1. Bates G. P., Mangiarini L., Davies S. W. Transgenic mice in the study of polyglutamine repeat expansion diseases. Brain Pathol. 8:1998;699-714.
2. Becher M. W., Kotzuk J. A., Sharp A. H., Davies S. W., Bates G. P., Price D. L., Ross C. A. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis. 4:1998;387-397.
3. Berezney R., Wei X. The new paradigm: Integrating genomic function and nuclear architecture. J. Cell. Biochem. (Suppl.). 30/31:1998;238-242.
4. Burright E. N., Clark H. B., Servadio A., Matilla T., Feddersen R. M., Yunis W. S., Duvick L. A., Zoghbi H. Y., Orr H. T. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell. 82:1995;937-948.
5. Clark H. B., Burright E. N., Yunis W. S., Larson S., Wilcox C., Hartman B., Matilla A., Zoghbi H. Y., Orr H. T. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J. Neurosci. 17:1997;7385-7395.
6. Cummings C. J., Reinstein E., Sun Y., Antalffy B., Jiang Y.-h., Ciechanover A., Orr H. T., Beaudet A. L., Zoghbi H. Y. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 transgenic mice. Neuron. 24:1999;879-892.
7. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., Bates G. P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:1997;537-548.
8. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993.
9. Doucas V., Tini M., Egan D. A., Evans R. M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA. 96:1999;2627-2632.
10. Ferrer I., Genis D., Davalos A., Bernado L., Sant F., Serrano T. The Purkinje cell in olivopontocerebellar atrophy. A Golgi and immunocytochemical study. Neuropathol. Appl. Neurobiol. 20:1994;38-46.
11. Holmberg M., Duyckaerts C., Dürr A., Cancel G., Gourfinkel-An I., Damier P., Faucheux B., Trottier Y., Hirsch E. C., Agid Y., Brice A. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 7:1998;913-918.
12. Kaytor M. D., Burright E. N., Duvick L. A., Zoghbi H. Y., Orr H. T. Increased trinucleotide repeat instability with advanced maternal age. Hum. Mol. Genet. 6:1997;2135-2159.
13. Kazeml-Esfarjani P., Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science. 287:2000;1837-1840.
14. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., Orr H. T. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 95:1998;41-53.
15. Koeppen A. H. The Purkinje cell and its afferents in human hereditary ataxia. J. Neuropathol. Exp. Neurol. 50:1991;505-514.
16. LaSpada A. R., Peterson K. R., Meadows S. A., McClain M. E., Jeng G., Chmelar R. S., Haugen H. A., Chen K., Singer M. J., Moore D., Trask B. J., Fischbeck K. H., Clegg C. H., McKnight G. S. Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. Hum. Mol. Genet. 7:1998;959-967.
17. Li M., Miwa S., Kobayashi Y., Merry D. E., Yamamoto M., Tanaka F., Doyu M., Hashizume Y., Fischbeck K. H., Sobue G. Nuclear inclusions of the androgen receptor in spinal and bulbar muscular atrophy. Ann. Neurol. 44:1998;249-254.
18. Lin X., Antalffy B., Kang D., Orrm H. T., Zoghbi H. Y. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci. 3:2000;157-163.
19. Managiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., Bates G. P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
20. Managiarini L., Sathasivam K., Mahal A., Mott R., Seller M., Bates G. P. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat. Genet. 15:1997;197-200.
21. Matilla A., Roberson E. D., Banfi S., Morales J., Armstrong D. L., Burright E. N., Orr H. T., Sweatt J. D., Zoghbi H. Y., Matzuk M. M. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J. Neurosci. 18:1998;5508-5516.
22. Paulson H. L., Perez M. K., Trottier Y., Trojanowsk J. Q., Subramony S. H., Das S. S., Vig P., Mandel J.-L., Fischbeck K. H., Pittman R. N. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 19:1999;333-334.
23. Sato T., Oyake M., Nakamura K., Nakao K., Fukusima Y., Onodera O., Igarashi S., Takano H., Kikugawa K., Ishida Y., Takayoshi S., Koide R., Ikeuchi T., Tanaka H., Futamura N., Matsummura R., Takayangi T., Tanaka F., Sobue G., Komure O., Takashi M., Sano A., Ichikawa Y., Goto J., Kanazawa I., Katsuki M., Tsuji S. Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. Hum. Mol. Genet. 8:1999;99-106.
24. Saudou F., Finkbeiner S., Devys D., Greenberg M. E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66.
25. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G. P., Davies S. W., Lehrach H., Wanker E. E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 90:1997;549-558.
26. Shelbourne P. F., Killeen N., Hevner R. F., Johnson H. M., Tecott L., Lewandoski M., Ennis M., Ramirez L., Li Z., Iannicola C., Littman D. R., Myers R. M. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet. 8:1999;115-122.
27. Skinner P. J., Koshy B., Cummings C., Klement I. A., Helin K., Servadio A., Zoghbi H. Y., Orr H. T. Ataxin-1 with extra glutamines induces alterations in nuclear matrix-associated structures. Nature. 389:1997;971-974.
28. Vig P. J. S., Fratkin J. D., Desaiah D., Currier R. D., Subramony S. H. Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia-1. Neurology. 47:1996;249-253.
29. Wheeler V. C., Auerbach W., White J. K., Srinidhi J., Auerbach A., Ryan A., Duyao M. P., Vrbanac V., Weaver M., Gusella J. F., Joyner A. L., MacDonald M. E. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet. 8:1999;115-122.
30. Yamamoto A., Lucas J. J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell. 101:2000;57-66.
31. Zoghbi H. Y., Orr H. T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23:2000;217-247.